INDIGO HORIZON LIMITED

Indigo Horizon Limited is a specialist supplier of premium, EU‑GMP‑certified medicinal cannabis, dedicated to meeting the needs of patients and healthcare professionals across Europe. Since its incorporation in 2019, the company has built a state‑of‑the‑art indoor cultivation facility that delivers patient‑specific, high‑quality cannabis products under the strictest safety and quality‑control standards.

Drawing on more than four decades of cannabis‑growing expertise, alongside extensive leadership experience in construction, finance and global banking, Indigo Horizon combines scientific rigour with commercial acumen to research, cultivate, process and distribute medicinal cannabis to pharmaceutical companies and clinical partners. The firm works closely with its clients, providing bespoke formulations that support a range of therapeutic areas, from epilepsy to chronic pain, and contributes to emerging evidence that cannabis can reduce seizure frequency and offer alternatives to opioid treatment.

Headquartered in Ponte da Barca, Viana do Castelo, Portugal, Indigo Horizon is positioning itself at the forefront of Europe’s medicinal‑c